263 related articles for article (PubMed ID: 20061398)
1. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.
Li IW; Hung IF; To KK; Chan KH; Wong SS; Chan JF; Cheng VC; Tsang OT; Lai ST; Lau YL; Yuen KY
Chest; 2010 Apr; 137(4):759-68. PubMed ID: 20061398
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
[TBL] [Abstract][Full Text] [Related]
3. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
[TBL] [Abstract][Full Text] [Related]
4. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
6. Viral load in patients infected with pandemic H1N1 2009 influenza A virus.
To KK; Chan KH; Li IW; Tsang TY; Tse H; Chan JF; Hung IF; Lai ST; Leung CW; Kwan YW; Lau YL; Ng TK; Cheng VC; Peiris JS; Yuen KY
J Med Virol; 2010 Jan; 82(1):1-7. PubMed ID: 19950247
[TBL] [Abstract][Full Text] [Related]
7. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
[TBL] [Abstract][Full Text] [Related]
8. Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
Antón A; López-Iglesias AA; Tórtola T; Ruiz-Camps I; Abrisqueta P; Llopart L; Marcos MÁ; Martínez MJ; Tudó G; Bosch F; Pahissa A; de Anta MT; Pumarola T
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):214-9. PubMed ID: 20955912
[TBL] [Abstract][Full Text] [Related]
9. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
[TBL] [Abstract][Full Text] [Related]
11. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children.
Li CC; Wang L; Eng HL; You HL; Chang LS; Tang KS; Lin YJ; Kuo HC; Lee IK; Liu JW; Huang EY; Yang KD
Emerg Infect Dis; 2010 Aug; 16(8):1265-72. PubMed ID: 20678321
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
[TBL] [Abstract][Full Text] [Related]
13. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of human influenza A(H7N9) infection in Hong Kong.
Leung YH; To MK; Lam TS; Yau SW; Leung OS; Chuang SK
J Microbiol Immunol Infect; 2017 Apr; 50(2):183-188. PubMed ID: 26220305
[TBL] [Abstract][Full Text] [Related]
15. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
Leung YH; Lim WL; Wong MH; Chuang SK
Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
[TBL] [Abstract][Full Text] [Related]
16. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
[TBL] [Abstract][Full Text] [Related]
17. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.
Viasus D; Paño-Pardo JR; Pachón J; Riera M; López-Medrano F; Payeras A; Fariñas MC; Moreno A; Rodríguez-Baño J; Oteo JA; Ortega L; Torre-Cisneros J; Segura F; Carratalà J;
Chest; 2011 Oct; 140(4):1025-1032. PubMed ID: 21415133
[TBL] [Abstract][Full Text] [Related]
18. Oseltamivir- and amantadine-resistant influenza virus A (H1N1).
Cheng PK; To AP; Leung TW; Leung PC; Lee CW; Lim WW
Emerg Infect Dis; 2010 Jan; 16(1):155-6. PubMed ID: 20031069
[No Abstract] [Full Text] [Related]
19. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
20. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.
Lee N; Hui DS; Zuo Z; Ngai KL; Lui GC; Wo SK; Tam WW; Chan MC; Wong BC; Wong RY; Choi KW; Sin WW; Lee EL; Tomlinson B; Hayden FG; Chan PK
Clin Infect Dis; 2013 Dec; 57(11):1511-9. PubMed ID: 24046309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
